SEC Form 4 · accession 0001225208-17-006070
PFIZER INC · PFE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Rady A Johnson
Officer — Executive Vice President
Period of report
Mar 9, 2017
Accepted (ET)
Mar 10, 2017 · 3:59 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000078003
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 9, 2017 | I | 4,405 | $34.05 | A | 4,821 | I | By Rule 16b-3 Plan |
| Common Stock | holding | — | — | — | 59,463 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction constitutes an intra-plan transfer involving the Pfizer stock fund under the Company's Qualified Savings Plan.